Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 77 entries
Sorted by: Best Match Show Resources per page
Development of NIST standard reference material 2373: Genomic DNA standards for HER2 measurements.

Biomolecular detection and quantification

He HJ, Almeida JL, Lund SP, Steffen CR, Choquette S, Cole KD.
PMID: 27335805
Biomol Detect Quantif. 2016 Mar 09;8:1-8. doi: 10.1016/j.bdq.2016.02.001. eCollection 2016 Jun.

NIST standard reference material (SRM) 2373 was developed to improve the measurements of the HER2 gene amplification in DNA samples. SRM 2373 consists of genomic DNA extracted from five breast cancer cell lines with different amounts of amplification of...

Cite
He HJ, Almeida JL, Lund SP, et al. Development of NIST standard reference material 2373: Genomic DNA standards for HER2 measurements. Biomol Detect Quantif. 2016;8:1-8doi: 10.1016/j.bdq.2016.02.001.
He, H. J., Almeida, J. L., Lund, S. P., Steffen, C. R., Choquette, S., & Cole, K. D. (2016). Development of NIST standard reference material 2373: Genomic DNA standards for HER2 measurements. Biomolecular detection and quantification, 81-8. https://doi.org/10.1016/j.bdq.2016.02.001
He, Hua-Jun, et al. "Development of NIST standard reference material 2373: Genomic DNA standards for HER2 measurements." Biomolecular detection and quantification vol. 8 (2016): 1-8. doi: https://doi.org/10.1016/j.bdq.2016.02.001
He HJ, Almeida JL, Lund SP, Steffen CR, Choquette S, Cole KD. Development of NIST standard reference material 2373: Genomic DNA standards for HER2 measurements. Biomol Detect Quantif. 2016 Mar 09;8:1-8. doi: 10.1016/j.bdq.2016.02.001. eCollection 2016 Jun. PMID: 27335805; PMCID: PMC4906140.
Copy Download .nbib Format: NLM
Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.

Current oncology (Toronto, Ont.)

Gagnon J, Lévesque E, Borduas F, Chiquette J, Diorio C, Duchesne N, Dumais M, Eloy L, Foulkes W, Gervais N, Lalonde L, L'Espérance B, Meterissian S, Provencher L, Richard J, Savard C, Trop I, Wong N, Knoppers BM, Simard J.
PMID: 28050152
Curr Oncol. 2016 Dec;23(6):e615-e625. doi: 10.3747/co.23.2961. Epub 2016 Dec 21.

In recent years, risk stratification has sparked interest as an innovative approach to disease screening and prevention. The approach effectively personalizes individual risk, opening the way to screening and prevention interventions that are adapted to subpopulations. The international perspective...

Cite
Gagnon J, Lévesque E, et al. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol. 2016;23(6):e615-e625doi: 10.3747/co.23.2961.
Gagnon, J., Lévesque, E., Borduas, F., Chiquette, J., Diorio, C., Duchesne, N., Dumais, M., Eloy, L., Foulkes, W., Gervais, N., Lalonde, L., L'Espérance, B., Meterissian, S., Provencher, L., Richard, J., Savard, C., Trop, I., Wong, N., Knoppers, B. M., & Simard, J. (2016). Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Current oncology (Toronto, Ont.), 23(6), e615-e625. https://doi.org/10.3747/co.23.2961
Gagnon, J, et al. "Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies." Current oncology (Toronto, Ont.) vol. 23,6 (2016): e615-e625. doi: https://doi.org/10.3747/co.23.2961
Gagnon J, Lévesque E, Borduas F, Chiquette J, Diorio C, Duchesne N, Dumais M, Eloy L, Foulkes W, Gervais N, Lalonde L, L'Espérance B, Meterissian S, Provencher L, Richard J, Savard C, Trop I, Wong N, Knoppers BM, Simard J. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol. 2016 Dec;23(6):e615-e625. doi: 10.3747/co.23.2961. Epub 2016 Dec 21. PMID: 28050152; PMCID: PMC5176389.
Copy Download .nbib Format: NLM
Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges.

Diabetes, metabolic syndrome and obesity : targets and therapy

Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P.
PMID: 29066925
Diabetes Metab Syndr Obes. 2017 Sep 13;10:375-383. doi: 10.2147/DMSO.S130810. eCollection 2017.

BACKGROUND: Lipodystrophy (LD; non-human immunodeficiency virus [HIV]-associated) syndromes are a rare body of disorders for which true prevalence is unknown. Prevalence estimates of rare diseases are important to increase awareness and financial resources. Current qualitative and quantitative estimates of...

Cite
Chiquette E, Oral EA, Garg A, et al. Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metab Syndr Obes. 2017;10:375-383doi: 10.2147/DMSO.S130810.
Chiquette, E., Oral, E. A., Garg, A., Araújo-Vilar, D., & Dhankhar, P. (2017). Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes, metabolic syndrome and obesity : targets and therapy, 10375-383. https://doi.org/10.2147/DMSO.S130810
Chiquette, Elaine, et al. "Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 10 (2017): 375-383. doi: https://doi.org/10.2147/DMSO.S130810
Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P. Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metab Syndr Obes. 2017 Sep 13;10:375-383. doi: 10.2147/DMSO.S130810. eCollection 2017. PMID: 29066925; PMCID: PMC5604558.
Copy Download .nbib Format: NLM
[Pulmonary cancer associated with tuberculosis].

Journal des sciences medicales de Lille

CLERC A, CRINQUETTE J.
PMID: 14382060
J Sci Med Lille. 1955 Apr;73(4):209-15.

No abstract available.

Cite
CLERC A, CRINQUETTE J. Tuberculose et cancer pulmonaire associés. [Pulmonary cancer associated with tuberculosis]. J Sci Med Lille. 1955;73(4):209-15
CLERC, A., & CRINQUETTE, J. (1955). Tuberculose et cancer pulmonaire associés. [Pulmonary cancer associated with tuberculosis]. Journal des sciences medicales de Lille, 73(4), 209-15.
CLERC, A, and CRINQUETTE, J. "Tuberculose et cancer pulmonaire associés." [Pulmonary cancer associated with tuberculosis]. Journal des sciences medicales de Lille vol. 73,4 (1955): 209-15.
CLERC A, CRINQUETTE J. Tuberculose et cancer pulmonaire associés. [Pulmonary cancer associated with tuberculosis]. J Sci Med Lille. 1955 Apr;73(4):209-15. PMID: 14382060.
Copy Download .nbib Format: NLM
[Bullous or deterged cavities during pulmonary tuberculosis].

Journal des sciences medicales de Lille

CRINQUETTE J, MAHIEU M.
PMID: 13812883
J Sci Med Lille. 1959 Nov;77:527-40.

No abstract available.

Cite
CRINQUETTE J, MAHIEU M. [Bullous or deterged cavities during pulmonary tuberculosis]. J Sci Med Lille. 1959;77:527-40
CRINQUETTE, J., & MAHIEU, M. (1959). [Bullous or deterged cavities during pulmonary tuberculosis]. Journal des sciences medicales de Lille, 77527-40.
CRINQUETTE, J, and MAHIEU, M. "[Bullous or deterged cavities during pulmonary tuberculosis]." Journal des sciences medicales de Lille vol. 77 (1959): 527-40.
CRINQUETTE J, MAHIEU M. [Bullous or deterged cavities during pulmonary tuberculosis]. J Sci Med Lille. 1959 Nov;77:527-40. French. PMID: 13812883.
Copy Download .nbib Format: NLM
New Year's Message from our President.

The Canadian veterinary journal = La revue veterinaire canadienne

Choquette L.
PMID: 17421290
Can Vet J. 1961 Jan;2(1):1-2.

No abstract available.

Cite
Choquette L. New Year's Message from our President. Can Vet J. 1961;2(1):1-2
Choquette, L. (1961). New Year's Message from our President. The Canadian veterinary journal = La revue veterinaire canadienne, 2(1), 1-2.
Choquette, L. "New Year's Message from our President." The Canadian veterinary journal = La revue veterinaire canadienne vol. 2,1 (1961): 1-2.
Choquette L. New Year's Message from our President. Can Vet J. 1961 Jan;2(1):1-2. PMID: 17421290; PMCID: PMC1585567.
Copy Download .nbib Format: NLM
Relative intensity correction of Raman spectrometers: NIST SRMs 2241 through 2243 for 785 nm, 532 nm, and 488 nm/514.5 nm excitation.

Applied spectroscopy

Choquette SJ, Etz ES, Hurst WS, Blackburn DH, Leigh SD.
PMID: 17331302
Appl Spectrosc. 2007 Feb;61(2):117-29. doi: 10.1366/000370207779947585.

Standard Reference Materials SRMs 2241 through 2243 are certified spectroscopic standards intended for the correction of the relative intensity of Raman spectra obtained with instruments employing laser excitation wavelengths of 785 nm, 532 nm, or 488 nm/514.5 nm. These...

Cite
Choquette SJ, Etz ES, Hurst WS, et al. Relative intensity correction of Raman spectrometers: NIST SRMs 2241 through 2243 for 785 nm, 532 nm, and 488 nm/514.5 nm excitation. Appl Spectrosc. 2007;61(2):117-29doi: 10.1366/000370207779947585.
Choquette, S. J., Etz, E. S., Hurst, W. S., Blackburn, D. H., & Leigh, S. D. (2007). Relative intensity correction of Raman spectrometers: NIST SRMs 2241 through 2243 for 785 nm, 532 nm, and 488 nm/514.5 nm excitation. Applied spectroscopy, 61(2), 117-29. https://doi.org/10.1366/000370207779947585
Choquette, Steven J, et al. "Relative intensity correction of Raman spectrometers: NIST SRMs 2241 through 2243 for 785 nm, 532 nm, and 488 nm/514.5 nm excitation." Applied spectroscopy vol. 61,2 (2007): 117-29. doi: https://doi.org/10.1366/000370207779947585
Choquette SJ, Etz ES, Hurst WS, Blackburn DH, Leigh SD. Relative intensity correction of Raman spectrometers: NIST SRMs 2241 through 2243 for 785 nm, 532 nm, and 488 nm/514.5 nm excitation. Appl Spectrosc. 2007 Feb;61(2):117-29. doi: 10.1366/000370207779947585. PMID: 17331302.
Copy Download .nbib Format: NLM
La Reproduction dans L'Industrie Animale.

Canadian journal of comparative medicine and veterinary science

Choquette P.
PMID: 17648919
Can J Comp Med Vet Sci. 1956 Oct;20(10):388-94.

No abstract available.

Cite
Choquette P. La Reproduction dans L'Industrie Animale. Can J Comp Med Vet Sci. 1956;20(10):388-94
Choquette, P. (1956). La Reproduction dans L'Industrie Animale. Canadian journal of comparative medicine and veterinary science, 20(10), 388-94.
Choquette, P. "La Reproduction dans L'Industrie Animale." Canadian journal of comparative medicine and veterinary science vol. 20,10 (1956): 388-94.
Choquette P. La Reproduction dans L'Industrie Animale. Can J Comp Med Vet Sci. 1956 Oct;20(10):388-94. PMID: 17648919; PMCID: PMC1614330.
Copy Download .nbib Format: NLM
Stability of detonation in a circular pipe with porous walls.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences

Chiquete C, Tumin A.
PMID: 22213664
Philos Trans A Math Phys Eng Sci. 2012 Feb 13;370(1960):668-88. doi: 10.1098/rsta.2011.0343.

A stability analysis is carried out taking into account slightly porous walls in an idealized detonation confined to a circular pipe. The analysis is carried out using the normal-mode approach and corrections are obtained to the underlying impenetrable wall...

Cite
Chiquete C, Tumin A. Stability of detonation in a circular pipe with porous walls. Philos Trans A Math Phys Eng Sci. 2012;370(1960):668-88doi: 10.1098/rsta.2011.0343.
Chiquete, C., & Tumin, A. (2012). Stability of detonation in a circular pipe with porous walls. Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 370(1960), 668-88. https://doi.org/10.1098/rsta.2011.0343
Chiquete, Carlos, and Tumin, Anatoli. "Stability of detonation in a circular pipe with porous walls." Philosophical transactions. Series A, Mathematical, physical, and engineering sciences vol. 370,1960 (2012): 668-88. doi: https://doi.org/10.1098/rsta.2011.0343
Chiquete C, Tumin A. Stability of detonation in a circular pipe with porous walls. Philos Trans A Math Phys Eng Sci. 2012 Feb 13;370(1960):668-88. doi: 10.1098/rsta.2011.0343. PMID: 22213664.
Copy Download .nbib Format: NLM
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts.

The Journal of rheumatology

Hazlewood GS, Bombardier C, Li X, Movahedi M, Choquette D, Coupal L, Bykerk VP, Schieir O, Mosher D, Marshall DA, Bernatsky S, Spencer N, Richards DP, Proulx L, Barber CEH.
PMID: 34334357
J Rheumatol. 2021 Aug 01; doi: 10.3899/jrheum.201688. Epub 2021 Aug 01.

OBJECTIVE: To compare clinical characteristics and treatment of patients with rheumatoid arthritis (RA) across 4 Canadian cohorts.METHODS: The 4 longitudinal cohorts included the following: the Canadian Early Arthritis Cohort (CATCH; n = 2878), Ontario Best Practices Research Initiative (OBRI;...

Cite
Hazlewood GS, Bombardier C, Li X, et al. Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. J Rheumatol. 2021;doi: 10.3899/jrheum.201688.
Hazlewood, G. S., Bombardier, C., Li, X., Movahedi, M., Choquette, D., Coupal, L., Bykerk, V. P., Schieir, O., Mosher, D., Marshall, D. A., Bernatsky, S., Spencer, N., Richards, D. P., Proulx, L., Barber, C. E. H. (2021). Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. The Journal of rheumatology, . https://doi.org/10.3899/jrheum.201688
Hazlewood, Glen S, et al. "Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts." The Journal of rheumatology vol. (2021). doi: https://doi.org/10.3899/jrheum.201688
Hazlewood GS, Bombardier C, Li X, Movahedi M, Choquette D, Coupal L, Bykerk VP, Schieir O, Mosher D, Marshall DA, Bernatsky S, Spencer N, Richards DP, Proulx L, Barber CEH. Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. J Rheumatol. 2021 Aug 01; doi: 10.3899/jrheum.201688. Epub 2021 Aug 01. PMID: 34334357.
Copy Download .nbib Format: NLM
Cooperation in publicly funded reference material production.

Accreditation and quality assurance : journal for quality, comparability and reliability in chemical measurement

Emteborg H, Florian D, Choquette S, Ellison SLR, Fernandes-Whaley M, Mackay L, McCarron P, Panne U, Sander SG, Kim SK, Held A, Linsinger T, Trapmann S.
PMID: 34131366
Accredit Qual Assur. 2018;23(6). doi: 10.1007/s00769-018-1349-1.

No abstract available.

Cite
Emteborg H, Florian D, Choquette S, et al. Cooperation in publicly funded reference material production. Accredit Qual Assur. 2018;23(6)doi: 10.1007/s00769-018-1349-1.
Emteborg, H., Florian, D., Choquette, S., Ellison, S. L. R., Fernandes-Whaley, M., Mackay, L., McCarron, P., Panne, U., Sander, S. G., Kim, S. K., Held, A., Linsinger, T., & Trapmann, S. (2018). Cooperation in publicly funded reference material production. Accreditation and quality assurance : journal for quality, comparability and reliability in chemical measurement, 23(6), . https://doi.org/10.1007/s00769-018-1349-1
Emteborg, Håkan, et al. "Cooperation in publicly funded reference material production." Accreditation and quality assurance : journal for quality, comparability and reliability in chemical measurement vol. 23,6 (2018). doi: https://doi.org/10.1007/s00769-018-1349-1
Emteborg H, Florian D, Choquette S, Ellison SLR, Fernandes-Whaley M, Mackay L, McCarron P, Panne U, Sander SG, Kim SK, Held A, Linsinger T, Trapmann S. Cooperation in publicly funded reference material production. Accredit Qual Assur. 2018;23(6). doi: 10.1007/s00769-018-1349-1. PMID: 34131366; PMCID: PMC8201643.
Copy Download .nbib Format: NLM
Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data.

Journal of personalized medicine

Alarie S, Hagan J, Dalpé G, Faraji S, Mbuya-Bienge C, Nabi H, Pashayan N, Brooks JD, Dorval M, Chiquette J, Eloy L, Turgeon A, Lambert-Côté L, Paquette JS, Walker MJ, Lapointe J, Granados Moreno P, Blackmore K, Wolfson M, Broeders M, The Perspective I I Study Group, Knoppers BM, Chiarelli AM, Simard J, Joly Y.
PMID: 34442372
J Pers Med. 2021 Jul 27;11(8). doi: 10.3390/jpm11080726.

The success of risk-stratified approaches in improving population-based breast cancer screening programs depends in no small part on women's buy-in. Fear of genetic discrimination (GD) could be a potential barrier to genetic testing uptake as part of risk assessment....

Cite
Alarie S, Hagan J, Dalpé G, et al. Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data. J Pers Med. 2021;11(8)doi: 10.3390/jpm11080726.
Alarie, S., Hagan, J., Dalpé, G., Faraji, S., Mbuya-Bienge, C., Nabi, H., Pashayan, N., Brooks, J. D., Dorval, M., Chiquette, J., Eloy, L., Turgeon, A., Lambert-Côté, L., Paquette, J. S., Walker, M. J., Lapointe, J., Granados Moreno, P., Blackmore, K., Wolfson, M., Broeders, M., The Perspective I I Study Group, Knoppers, B. M., Chiarelli, A. M., Simard, J., & Joly, Y. (2021). Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data. Journal of personalized medicine, 11(8), . https://doi.org/10.3390/jpm11080726
Alarie, Samuel, et al. "Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data." Journal of personalized medicine vol. 11,8 (2021). doi: https://doi.org/10.3390/jpm11080726
Alarie S, Hagan J, Dalpé G, Faraji S, Mbuya-Bienge C, Nabi H, Pashayan N, Brooks JD, Dorval M, Chiquette J, Eloy L, Turgeon A, Lambert-Côté L, Paquette JS, Walker MJ, Lapointe J, Granados Moreno P, Blackmore K, Wolfson M, Broeders M, The Perspective I I Study Group, Knoppers BM, Chiarelli AM, Simard J, Joly Y. Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data. J Pers Med. 2021 Jul 27;11(8). doi: 10.3390/jpm11080726. PMID: 34442372; PMCID: PMC8398750.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 77 entries